home · filing · 0000950170-25-002291
8-K
filed January 6, 2025, 6:59 PM ET
ticker MNKD
CIK 0000899460
leadership
confidence high
sentiment neutral
materiality 0.50
Lauren Sabella to retire from MannKind July 18, 2025; appointed EVP, Operations
MANNKIND CORP
Lauren Sabella notified retirement effective July 18, 2025.
Board appointed Sabella as Executive Vice President, Operations effective January 6, 2025.
Sabella remains on executive leadership team until retirement but will no longer oversee Endocrine Business Unit.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2025-01-06
Filed January 6, 2025, 6:59 PM ET
the board of directors of the Company appointed Ms. Sabella as Executive Vice President, Operations, effective January 6, 2025.
Effective 2025-07-18
Filed January 6, 2025, 6:59 PM ET
On January 2, 2025, Lauren Sabella notified us of her intention to retire from MannKind Corporation (the “Company”), effective July 18, 2025
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Lauren Sabella was appointed as Executive Vice President, Operations at MANNKIND CORP.
Action appointed
Role Executive Vice President, Operations
Exact text from the filing
the board of directors of the Company appointed Ms. Sabella as Executive Vice President, Operations, effective January 6, 2025.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Lauren Sabella departed as Executive Vice President, Operations at MANNKIND CORP.
Action intends to retire
Role Executive Vice President, Operations
Exact text from the filing
On January 2, 2025, Lauren Sabella notified us of her intention to retire from MannKind Corporation (the “Company”), effective July 18, 2025
View on SEC.gov
Source: SEC EDGAR
accession 0000950170-25-002291
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.